Skip to main content
logo
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9489
+0.1039 (12.30%)
Aug 14, 2026, 4:00 PM EDT - Market closed

CytoMed Therapeutics Financials Overview

Millions SGD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.860.860.50.510.360.11
Revenue Growth
17.95%71.02%-0.86%39.52%219.67%91.43%
Gross Profit
0.770.770.470.50.360.11
Operating Income
-4.23-4.23-3.13-3.84-1.86-1.74
Net Income
-3.98-3.98-2.52-4.13-3.13-2.05
Earnings Per Share
-0.34-0.34-0.22-0.39-0.40-0.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.12.14.9791.582.53
Total Debt
0.480.480.460.454.223.26
Net Cash (Debt)
1.611.614.518.55-2.64-0.73
Net Cash Growth
-31.81%-64.21%-47.27%---
Net Cash Per Share
0.140.140.390.80-0.33-0.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.7-3.7-2.71-3.53-1.4-1.71
Capital Expenditures
-0.64-0.64-1.4-0.06-0.47-0.58
Free Cash Flow
-4.34-4.34-4.11-3.59-1.87-2.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
89.57%89.57%93.83%99.27%97.60%96.92%
Operating Margin
-491.75%-491.75%-621.91%-756.86%-511.02%-1528.84%
Pretax Margin
-464.23%-464.23%-500.99%-813.91%-860.05%-1802.43%
Profit Margin
-462.39%-462.39%-499.97%-813.98%-860.43%-1802.21%
FCF Margin
-503.61%-503.61%-816.52%-706.96%-514.47%-2016.27%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.7823.02106.38146.86--